Further, in mouse models, combined EBRT and IT hu14.18-IL2 (IT-IC) create an in situ vaccine effect resulting in enhanced tumor response characterized by NK cell and CD8+ T cell infiltration, along with an antitumor memory T cell response [27]. Here, IL2 is linked to neoplasm.